Seer, Inc. (SEER)
NASDAQ: SEER · Real-Time Price · USD
2.430
+0.050 (2.10%)
Nov 22, 2024, 4:00 PM EST - Market closed
Seer, Inc. Revenue
Seer, Inc. had revenue of $4.03M in the quarter ending September 30, 2024, a decrease of -3.12%. This brings the company's revenue in the last twelve months to $14.61M, down -13.19% year-over-year. In the year 2023, Seer, Inc. had annual revenue of $16.66M with 7.54% growth.
Revenue (ttm)
$14.61M
Revenue Growth
-13.19%
P/S Ratio
10.58
Revenue / Employee
$99,374
Employees
147
Market Cap
143.29M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Seres Therapeutics | 126.33M |
Fennec Pharmaceuticals | 49.35M |
Cidara Therapeutics | 44.65M |
Sensus Healthcare | 41.31M |
TriSalus Life Sciences | 26.89M |
Elutia | 24.78M |
Vaxart | 16.76M |
SEER News
- 2 days ago - Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™ - GlobeNewsWire
- 15 days ago - Seer to Participate in Upcoming November Investor Conferences - GlobeNewsWire
- 16 days ago - Seer, Inc. (SEER) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 17 days ago - Seer Enters into a Co-Marketing and Sales Agreement with Thermo Fisher Scientific - GlobeNewsWire
- 23 days ago - Seer Highlights Capability of Deep Proteomics to Enhance Genomic Insights Into Alzheimer's, Lung Cancer, and More at ASHG 2024 - GlobeNewsWire
- 4 weeks ago - Seer Showcases Scalable Proteomic Advancements Impacting Alzheimer's, Population Health, and Xenotransplantation at HUPO 2024 - GlobeNewsWire
- 3 months ago - Seer to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference - GlobeNewsWire
- 3 months ago - Seer Appoints Nicolas Roelofs to its Board of Directors - GlobeNewsWire